Litchfield Hills Research Stock Recommendations and Price Targets

This is a list of recent ratings by Litchfield Hills Research.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
11/30/2021
ADIL
Adial Pharmaceuticals
Reiterated Rating$3.00BuyLow
11/22/2021
KULR
KULR Technology Group
Reiterated Rating$3.00BuyMedium
11/19/2021
WLMS
Williams Industrial Services Group
Reiterated Rating$3.00BuyMedium
11/17/2021
COMS
COMSovereign
Reiterated Rating$1.00BuyLow
11/17/2021
STRR
Star Equity
Reiterated Rating$3.00BuyHigh
11/16/2021
POAI
Predictive Oncology
Reiterated Rating$1.00BuyMedium
11/15/2021
CODX
Co-Diagnostics
Reiterated Rating$9.00BuyHigh
11/2/2021
BELFB
Bel Fuse
Reiterated Rating$12.00BuyMedium
10/28/2021
GHM
Graham
Reiterated Rating$13.00BuyLow
9/20/2021
RYMDF
Relay Medical
Reiterated Rating$0.00BuyLow
9/16/2021
OTLC
Oncotelic Therapeutics
Reiterated Rating$0.00BuyLow
8/27/2021
AVNW
Aviat Networks
Reiterated Rating$31.00BuyLow
8/26/2021
ADIL
Adial Pharmaceuticals
Boost Price Target$3.00$5.00 ➝ $15.00BuyHigh
6/29/2021
ADIL
Adial Pharmaceuticals
Initiated Coverage$3.00 $5.00BuyLow
2/1/2021
POAI
Predictive Oncology
Initiated Coverage$1.00 $3.00BuyLow
12/7/2020
MATN
Mateon Therapeutics
Initiated Coverage$0.00 $3.00BuyHigh
4/22/2019
GHM
Graham
Initiated Coverage$13.00 $1.59BuyLow